164 related articles for article (PubMed ID: 10810873)
1. [Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody].
Ieko M
Rinsho Byori; 2000 Apr; 48(4):293-300. PubMed ID: 10810873
[TBL] [Abstract][Full Text] [Related]
2. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies.
Ieko M; Sawada KI; Koike T; Notoya A; Mukai M; Kohno M; Wada N; Itoh T; Yoshioka N
Semin Thromb Hemost; 1999; 25(5):503-7. PubMed ID: 10625210
[TBL] [Abstract][Full Text] [Related]
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of F1 + 2/TAT ratios in Japanese patients with antiphospholipid syndrome].
Naitoh S; Ieko M; Takeda M; Atsumi T; Koike T
Rinsho Byori; 2000 Jun; 48(6):540-6. PubMed ID: 10897673
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.
Ieko M; Ichikawa K; Triplett DA; Matsuura E; Atsumi T; Sawada K; Koike T
Arthritis Rheum; 1999 Jan; 42(1):167-74. PubMed ID: 9920027
[TBL] [Abstract][Full Text] [Related]
7. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid syndrome].
Atsumi T; Koike T
Nihon Rinsho; 1998 Jan; 56(1):215-23. PubMed ID: 9465693
[TBL] [Abstract][Full Text] [Related]
12. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1.
Atsumi T; Khamashta MA; Haworth RS; Brooks G; Amengual O; Ichikawa K; Koike T; Hughes GR
Arthritis Rheum; 1998 May; 41(5):800-7. PubMed ID: 9588730
[TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
16. Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.
Wang MX; Kandiah DA; Ichikawa K; Khamashta M; Hughes G; Koike T; Roubey R; Krilis SA
J Immunol; 1995 Aug; 155(3):1629-36. PubMed ID: 7543528
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies and thrombosis.
Brighton TA; Chesterman CN
Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
[TBL] [Abstract][Full Text] [Related]
18. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies.
Lázaro I; Carmona F; Reverter JC; Cervera R; Tassies D; Balasch J
Am J Obstet Gynecol; 2009 Jul; 201(1):87.e1-6. PubMed ID: 19427615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
